| Trial registration number
|
NCT05212480 |
Full text link
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT05212480
|
First author
Last imported at : May 12, 2022, 6:30 a.m.
Source : ClinicalTrials.gov
|
Semir Nouira
|
Contact
Last imported at : May 12, 2022, 6:30 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
2022-01-28
|
Recruitment status
Last imported at : May 12, 2022, 6:30 a.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : May 12, 2022, 6:30 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
age 18 years and over .
sars-cov2 infection diagnosed with rt pcr , rapid test or chest ct-scan performed within the less than 5 days of symptoms.
|
Exclusion criteria
Last imported at : May 12, 2022, 6:30 a.m.
Source : ClinicalTrials.gov
|
patients who received zinc before the start of the protocol.
heart, liver, malignancies, or renal failure (estimated glomerular filtration rate ≤30 ml/min/1.73 m2);
mental disorders .
chronic dialysis.
hospitalisation in icu (use of respiratory or cardiovascular organ support (oxygen delivered by high-flow nasal cannula, noninvasive or invasive mechanical ventilation, or the use of vasopressors or inotropes). .
known hypersensitivity to zinc.
unsuitability for oral administration
|
Number of arms
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
University of Monastir
|
Inclusion age min
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
90
|
Countries
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Tunisia
|
Type of patients
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Moderate/severe disease at enrollment
|
Severity scale
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
4: Moderate/severe disease at enrollment
|
Total sample size
Last imported at : May 12, 2022, 6:30 a.m.
Source : ClinicalTrials.gov
|
460
|
primary outcome
Last imported at : May 12, 2022, 6:30 a.m.
Source : ClinicalTrials.gov
|
Combined_outcome;Mortality rate.;need for ICU admission;treatment safety
|
Notes
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Jan. 29, 2022, 11:30 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 1397, "treatment_name": "Zinc", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|